Skip to content
ppharmaranks
Menu

NINTEDANIB ESYLATE vs TABRECTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. NINTEDANIB ESYLATE and TABRECTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

New
70/100

Pharmacy pays

Type

RX
RX

Active ingredient

NINTEDANIB ESYLATE
CAPMATINIB HYDROCHLORIDE

Manufacturer

Dosage forms

Capsule
Tablet

Drug class

Kinase Inhibitor
Kinase Inhibitor

Boxed warning

None
None

Treats

Idiopathic Pulmonary Fibrosis
Non-Small-Cell Lung Carcinoma

Frequently asked questions

What is the difference between Nintedanib Esylate and Tabrecta?

Nintedanib Esylate contains Nintedanib Esylate, while Tabrecta contains Capmatinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.